Oncology & Cancer

Considerable surgeon-level variation in radical prostatectomy

(HealthDay)—Considerable practice variation exists among surgeons at a high-volume academic center when selecting patients with prostate cancer to undergo radical prostatectomy, according to a study published in the March ...

Oncology & Cancer

PDE-5 inhibitors tied to prostate cancer biochemical recurrence

(HealthDay)—Phosphodiesterase type 5 inhibitor use after radical prostatectomy is associated with increased risk of biochemical recurrence, according to a study published in the February issue of The Journal of Urology.

Oncology & Cancer

ASCO endorses guideline for radiation after prostatectomy

(HealthDay)—The American Society for Clinical Oncology (ASCO) has endorsed a recent guideline for adjuvant and salvage radiotherapy after prostatectomy. The endorsement was published online Nov. 3 in the Journal of Clinical ...

Surgery

High-volume surgeons lead use of robotic procedures

(HealthDay)—From 2003 to 2010 there was widespread adoption of robot-assisted radical prostatectomy (RARP), especially among high-volume surgeons, according to a study published online Aug. 26 in BJU International.

page 7 from 17